Highbridge Capital Management LLC Regenxbio Inc. Transaction History

Highbridge Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$27.2 - $74.35 $1.63 Million - $4.46 Million	-60,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$24.05 - $37.5 $481,000 - $750,000	20,000 Added 50.0%	60,000 $1.79 Million
Q4 2017 Feb 14, 2018	BUY	$26.0 - $34.6 $1.04 Million - $1.38 Million	40,000 New	40,000 $1.33 Million
Q3 2017 Nov 14, 2017	SELL	$18.0 - $32.95 $720,000 - $1.32 Million	-40,000 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	40,000	40,000 $790,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.